Source: https://profiles.superlawyers.com/washington-dc/washington/lawyer/kirk-ogrosky/7a1c4716-e417-4af9-abb3-ccfd1b478c0d.html
Timestamp: 2019-04-26 15:58:03+00:00

Document:
Kirk Ogrosky is an accomplished trial attorney who represents clients in civil and criminal enforcement actions, government investigations, and global anti-corruption matters. He has a distinguished record of conducting internal investigations, implementing corrective action plans, and negotiating favorable resolutions. A zealous advocate, he has handled multi-billion-dollar disputes in alleged fraud matters, and has taken over 40 defendants to verdict in federal jury trials over the past 20 years. In 2017 alone, he spent 18 weeks in trial before federal juries in multiple jurisdictions.
He clerked for United States District Judge Patricia A. Seitz in the Southern District of Florida. He teaches the annual healthcare fraud and abuse course at Georgetown Law School. He is a graduate of Washington University in St. Louis and The George Washington University Law School.
Led successful defense in 10 week federal trial against prominent surgeon on charges of public corruption and bribery. US v. Melgen, et al., Case No. 1:15-CR-00155 (D.N.J. 2017) (Court granted acquittal for all political contribution counts after mistrial where jurors voted 10 to 2 to acquit. DOJ dismissed remaining counts with prejudice). Led successful defense in 5 week federal trial against prominent Mohs surgeon on charges of healthcare fraud, aggravated identity theft, and obstruction of justice. US v. Bajoghli, Case No. 1:14-CR-278 (E.D.VA. 2015)(client acquitted of all charges). Recent selection of public False Claims Act cases include: U.S., ex rel. Dickson, v. Bristol-Myers Squibb, et al., Case No. 3:13-cv-01039 (S.D. IL)(declined and case dismissed); U.S., ex rel. JKJ Partnership, et al., v. Sanofi-Aventis U.S., et al., Case No. 3:11-CV-6476 (DNJ)(declined and case pending); U.S., ex rel. CIMZNHCA LLC, et al., v. UCB, Inc., et al., Case No. 17-cv-765 (S.D. IL)(declined and case pending); U.S., ex rel. Rudolph, et al., v. ISS Holdings LTD., et al., Case No. 10-1109 (D.D.C.)(case pending); U.S., ex rel. Doe, et al., v. Ferring Pharmaceuticals, Inc., et al., Case No. 3:12-CV-542 (M.D. TN 2012)(case dismissed); U.S., ex rel. Dennis v. University Medical Center, No. 3:09-cv-00484 (M.D. TN)(declined and case dismissed); U.S., ex rel. Williams v. HMA, et al., Case No. 3:09-CV-130 (M.D. GA)(case dismissed); U.S., ex rel. Adams v. VMR Institute, Inc., Case No. 10-407 AG (C.D. CA)(case dismissed); and U.S. v. New York Heart Center, et al. (Stark law case resolved prior to filing).

References: v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v.